FYERS
Home
/
Stocks
/
Results
/
Acutaas Chemicals Results

Acutaas Chemicals Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
24%32%29%33%
40%46%62%122%
--69%127%
26%17%16%24%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
LUPIN
MANKIND
DRREDDY
AUROPHARMA
ACUTAAS
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,899₹456833 Cr37.7712.0762.82₹11479 Cr
9,100₹245426 Cr83.9134.04128.41₹2568 Cr
4,857₹187320 Cr85.8916.7297.06₹2163 Cr
1,120₹113217 Cr25.099.4262.53₹5040 Cr
1,385₹112212 Cr33.299.7757.87₹3879 Cr
1,840₹101155 Cr92.526.829.25₹889 Cr
2,110₹97626 Cr17.6630.95154.36₹5333 Cr
2,327.9₹96859 Cr47.4213.7571.08₹1913 Cr
1,151₹96406 Cr29.925.3263.99₹4196 Cr
1,653.1₹93614 Cr25.2217.9596.84₹3505 Cr
3,169₹26194 Cr67.829.0751.78₹356 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020
₹330 Cr₹433 Cr₹393 Cr₹306 Cr₹207 Cr₹308 Cr₹275 Cr₹247 Cr₹177 Cr₹225 Cr₹166 Cr₹172 Cr₹142 Cr₹186 Cr₹152 Cr₹147 Cr₹131 Cr₹144 Cr₹141 Cr₹122 Cr₹113 Cr₹93 Cr₹92 Cr₹91 Cr
₹2 Cr₹11 Cr₹5 Cr₹10 Cr₹16 Cr₹6 Cr₹2 Cr₹8 Cr₹1 Cr₹1 Cr₹3 Cr₹2 Cr₹1 Cr-₹17 L₹3 Cr₹85 L₹62 L₹18 L₹1 Cr₹16 L₹1 Cr₹20,000₹17 L₹1 Cr
₹331 Cr₹444 Cr₹398 Cr₹316 Cr₹223 Cr₹314 Cr₹277 Cr₹255 Cr₹178 Cr₹226 Cr₹170 Cr₹174 Cr₹143 Cr₹186 Cr₹155 Cr₹148 Cr₹132 Cr₹144 Cr₹143 Cr₹122 Cr₹114 Cr₹93 Cr₹92 Cr₹92 Cr
₹226 Cr₹259 Cr₹252 Cr₹219 Cr₹164 Cr₹231 Cr₹213 Cr₹205 Cr₹153 Cr₹187 Cr₹144 Cr₹151 Cr₹121 Cr₹149 Cr₹125 Cr₹122 Cr₹111 Cr₹121 Cr₹114 Cr₹97 Cr₹93 Cr₹71 Cr₹71 Cr₹71 Cr
₹115 Cr₹195 Cr₹155 Cr₹105 Cr₹67 Cr₹91 Cr₹70 Cr₹57 Cr₹31 Cr₹45 Cr₹30 Cr₹26 Cr₹26 Cr₹41 Cr₹34 Cr₹29 Cr₹24 Cr₹26 Cr₹31 Cr₹28 Cr₹23 Cr₹23 Cr₹22 Cr₹23 Cr
₹1 Cr₹1 Cr₹86 L₹58 L₹64 L₹60 L₹69 L₹50 L₹4 Cr₹2 Cr₹3 Cr₹82 L₹51 L₹59 L₹1 Cr₹45 L₹18 L₹59 L₹34 L₹3 Cr₹3 Cr₹1 Cr₹2 Cr₹1 Cr
₹104 Cr₹184 Cr₹145 Cr₹96 Cr₹58 Cr₹83 Cr₹63 Cr₹50 Cr₹20 Cr₹37 Cr₹24 Cr-₹10 Cr₹22 Cr₹37 Cr₹30 Cr₹26 Cr₹20 Cr₹22 Cr₹29 Cr₹23 Cr₹18 Cr₹21 Cr₹19 Cr₹20 Cr
₹75 Cr₹134 Cr₹106 Cr₹72 Cr₹44 Cr₹63 Cr₹45 Cr₹38 Cr₹15 Cr₹26 Cr₹18 Cr-₹17 Cr₹17 Cr₹27 Cr₹22 Cr₹19 Cr₹15 Cr₹21 Cr₹19 Cr₹17 Cr₹14 Cr₹15 Cr₹14 Cr₹15 Cr

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
———————————
₹41 Cr₹41 Cr₹37 Cr₹36 Cr₹36 Cr₹32 Cr₹11 Cr₹11 Cr₹2 Cr₹2 Cr₹2 Cr
₹3 Cr₹11 L₹2 Cr₹0₹0₹0₹0₹0₹0₹0₹0
₹1610 Cr₹1269 Cr₹635 Cr₹558 Cr₹486 Cr₹135 Cr₹101 Cr₹72 Cr₹56 Cr₹37 Cr₹26 Cr
₹1610 Cr₹1269 Cr₹635 Cr₹558 Cr₹486 Cr₹135 Cr₹101 Cr₹72 Cr₹56 Cr₹37 Cr₹26 Cr
₹1654 Cr₹1310 Cr₹674 Cr₹594 Cr₹522 Cr₹167 Cr₹112 Cr₹82 Cr₹58 Cr₹39 Cr₹27 Cr
₹57 Cr₹10 Cr₹9 Cr₹0₹0₹0₹0₹0₹0₹0₹0
₹0₹0₹114 Cr₹63 L₹59 L₹72 Cr₹13 Cr₹12 Cr₹28 Cr₹14 Cr₹14 Cr
₹0₹0₹0₹0₹0₹82 L₹7 Cr₹11 Cr₹4 Cr₹47 L₹2 Cr
₹29 Cr₹20 Cr₹13 Cr₹9 Cr₹6 Cr₹3 Cr₹3 Cr₹2 Cr-₹3 L-₹4 L-₹1 Cr
₹9 Cr₹5 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹5 Cr₹3 Cr₹1 Cr₹68 L₹44 L₹4 Cr₹2 Cr₹1 Cr₹98 L₹63 L₹37 L
₹42 Cr₹27 Cr₹128 Cr₹10 Cr₹7 Cr₹80 Cr₹25 Cr₹25 Cr₹33 Cr₹15 Cr₹15 Cr
———————————
₹154 Cr₹156 Cr₹135 Cr₹142 Cr₹118 Cr₹85 Cr₹51 Cr₹68 Cr₹48 Cr₹38 Cr₹28 Cr
₹12 Cr₹13 Cr₹65 Cr₹7 Cr₹5 Cr₹35 Cr₹9 Cr₹11 Cr₹3 Cr₹5 Cr₹5 Cr
₹26 Cr₹8 Cr₹73 Cr₹3 Cr₹0₹45 Cr₹34 Cr₹26 Cr₹9 Cr₹9 Cr₹11 Cr
₹38 Cr₹25 Cr₹13 Cr₹11 Cr₹6 Cr₹2 Cr₹41 L₹51 L₹4 Cr₹2 Cr₹4 Cr
₹231 Cr₹202 Cr₹285 Cr₹163 Cr₹129 Cr₹166 Cr₹95 Cr₹106 Cr₹65 Cr₹55 Cr₹49 Cr
₹1984 Cr₹1549 Cr₹1096 Cr₹767 Cr₹659 Cr₹413 Cr₹232 Cr₹213 Cr₹155 Cr₹109 Cr₹91 Cr
₹17 Cr₹15 Cr₹2 Cr₹3 Cr₹3 Cr₹19,000₹7 L₹8 L₹0₹0₹0
₹26 Cr₹8 Cr₹217 Cr₹4 Cr₹84 L₹137 Cr₹59 Cr₹54 Cr₹44 Cr₹27 Cr₹30 Cr
———————————
₹862 Cr₹652 Cr₹482 Cr₹298 Cr₹231 Cr₹203 Cr₹98 Cr₹91 Cr₹41 Cr₹35 Cr₹25 Cr
₹117 Cr₹81 Cr₹55 Cr₹39 Cr₹27 Cr₹17 Cr₹13 Cr₹12 Cr₹10 Cr₹8 Cr₹6 Cr
₹745 Cr₹570 Cr₹427 Cr₹259 Cr₹205 Cr₹186 Cr₹85 Cr₹79 Cr₹32 Cr₹28 Cr₹18 Cr
₹332 Cr₹130 Cr₹125 Cr₹26 Cr₹2 Cr₹20 L₹12 Cr₹2 Cr₹30 Cr₹11 Cr₹4 Cr
₹20 L₹20 L₹20 L₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹3 Cr₹1 Cr₹1 Cr
₹20 L₹20 L₹20 L₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹3 Cr₹1 Cr₹1 Cr
₹24 Cr₹56 Cr₹49 Cr₹17 Cr₹14 Cr₹2 Cr₹3 Cr₹2 Cr₹76 L₹54 L₹48 L
₹91 L₹88 L₹1 Cr₹2 Cr₹6 Cr₹1 Cr₹4 Cr₹79 L₹1 Cr₹1 Cr₹80 L
₹1103 Cr₹758 Cr₹603 Cr₹310 Cr₹229 Cr₹191 Cr₹105 Cr₹85 Cr₹66 Cr₹42 Cr₹25 Cr
———————————
₹231 Cr₹180 Cr₹157 Cr₹119 Cr₹112 Cr₹60 Cr₹52 Cr₹39 Cr₹27 Cr₹20 Cr₹20 Cr
₹363 Cr₹290 Cr₹206 Cr₹230 Cr₹164 Cr₹121 Cr₹56 Cr₹76 Cr₹50 Cr₹36 Cr₹36 Cr
₹225 Cr₹249 Cr₹53 Cr₹59 Cr₹100 Cr₹3 Cr₹4 Cr₹49 L₹1 Cr₹4 Cr₹51 L
₹5 Cr₹3 Cr₹4 Cr₹8 Cr₹11 Cr₹12 Cr₹16 L₹32 L₹13 L₹39 L₹24 L
₹57 Cr₹69 Cr₹72 Cr₹41 Cr₹43 Cr₹21 Cr₹8 Cr₹9 Cr₹9 Cr₹6 Cr₹9 Cr
₹881 Cr₹792 Cr₹493 Cr₹457 Cr₹430 Cr₹216 Cr₹121 Cr₹124 Cr₹87 Cr₹66 Cr₹66 Cr
₹650 Cr₹589 Cr₹208 Cr₹294 Cr₹300 Cr₹50 Cr₹26 Cr₹19 Cr₹22 Cr₹12 Cr₹18 Cr
₹0₹0₹0₹0₹0₹6 Cr₹6 Cr₹4 Cr₹2 Cr₹12 L₹17 L
₹1984 Cr₹1549 Cr₹1096 Cr₹767 Cr₹659 Cr₹413 Cr₹232 Cr₹213 Cr₹155 Cr₹109 Cr₹91 Cr
₹202₹160₹182₹163₹143₹51₹101₹75₹373₹259₹182
₹202₹80₹91₹82₹143₹17₹34₹25₹18₹12₹9

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
₹483 Cr₹216 Cr₹82 Cr₹112 Cr₹91 Cr₹72 Cr₹35 Cr₹35 Cr₹28 Cr₹19 Cr₹18 Cr
₹14 Cr₹19 Cr₹50 Cr₹14 Cr₹14 Cr₹8 Cr₹10 Cr₹7 Cr₹4 Cr₹4 Cr₹3 Cr
-₹93 Cr-₹70 Cr₹18 Cr-₹36 Cr-₹94 Cr-₹38 Cr-₹9 Cr-₹14 Cr-₹17 Cr₹13 Cr-₹8 Cr
₹404 Cr₹165 Cr₹150 Cr₹90 Cr₹11 Cr₹42 Cr₹35 Cr₹29 Cr₹16 Cr₹35 Cr₹13 Cr
₹292 Cr₹118 Cr₹125 Cr₹66 Cr-₹12 Cr₹28 Cr₹27 Cr₹15 Cr₹8 Cr₹29 Cr₹10 Cr
-₹266 Cr-₹224 Cr-₹365 Cr-₹33 Cr-₹121 Cr-₹101 Cr-₹24 Cr-₹21 Cr-₹25 Cr-₹19 Cr-₹14 Cr
₹4 Cr₹261 Cr₹239 Cr-₹12 Cr₹140 Cr₹72 Cr₹19 L₹6 Cr₹15 Cr-₹7 Cr₹4 Cr
₹30 Cr₹156 Cr-₹86 L₹20 Cr₹8 Cr-₹1 Cr₹3 Cr-₹41 L-₹2 Cr₹3 Cr-₹70,000
₹185 Cr₹30 Cr₹31 Cr₹10 Cr₹3 Cr₹4 Cr₹49 L₹90 L₹3 Cr₹32 L₹33 L
₹0₹0₹3 L₹0₹0-₹6,000₹0₹0-₹30,000-₹10,000-₹10,000
₹216 Cr₹185 Cr₹30 Cr₹31 Cr₹10 Cr₹3 Cr₹4 Cr₹49 L₹90 L₹3 Cr₹32 L

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)3,211.10
Volume (₹)1.50 L
High (₹)3,228.80
Upper Circuit3,841.20
Low (₹)3,156.30
Lower Circuit2,560.80
Prev Close3,201.00
52W High (₹)3,740.00
Price3,169.00
52W Low (₹)1,302.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)26194.30 Cr
Div. Yield (%)0.08
PE Ratio67.82
Debt to Equity0.02
Price to Book12.69
Book Value201.59
EPS (TTM)47.17
Face Value5.00
ROE (%)24.08

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
ACUTAASNSE
LTP
1W Low
1W High
Market cap (₹)
1899-21 (-1.09%)
1895
1984.80
4,56,833Cr
9100-139 (-1.50%)
9087
9467
2,45,426Cr
4857-193 (-3.82%)
4823
5066
1,87,320Cr
1120-71 (-5.96%)
1120
1187
1,13,217Cr
1385-38.5 (-2.70%)
1375.50
1426.10
1,12,212Cr
1840-98.5 (-5.08%)
1811.70
1949
1,01,155Cr
2110-61.5 (-2.83%)
2100.60
2192
97,626Cr
2327.9-55 (-2.31%)
2317
2419.20
96,859Cr
1151-27 (-2.29%)
1151
1179.90
96,406Cr
1653.1+7.8 (0.47%)
1622.60
1717
93,614Cr
3169-112.6 (-3.43%)
3120
3321.90
26,194Cr

Acutaas Chemicals Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹114.87Cr; with other income of ₹1.8Cr, profit before interest and tax came to ₹105.05Cr. Interest expense was ₹1.14Cr; PBT before exceptional items stood at ₹103.91Cr. Cost mix (full year): raw materials ₹594.96Cr; employee cost ₹117.57Cr; depreciation ₹9.82Cr; other expenses ₹216.6Cr. Basis: consolidated annual results.

Acutaas Chemicals Ltd Quaterly Results Key Takeaways

Acutaas Chemicals Ltd reported ₹329.68Cr total income from operations in Jun 2026, softer than ₹432.75Cr in Mar 2026 but higher than ₹207.24Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹114.87Cr; with other income of ₹1.8Cr, profit before interest and tax came to ₹105.05Cr. Interest expense was ₹1.14Cr, taking profit before tax to ₹103.91Cr. After tax of ₹28.92Cr, profit after tax stood at ₹74.99Cr (vs ₹134.28Cr in Mar 2026 and ₹44.01Cr in Jun 2025).